Dräger makes changes to Executive Board

Carla Kriwet will take responsibility for marketing and sales on 1 January 2011

The Supervisory Board of Drägerwerk Verwaltungs has appointed Dr Carla Kriwet as a new Executive Board member, who will take responsibility for marketing and sales on 1 January 2011.

Kriwet currently works for Linde Group as head of Healthcare Europe for the Division Hospital Care and Homecare in Central and Northern Europe.



Dr Dieter Pruss, currently responsible for marketing and sales for the safety division on the Executive Board, will leave the company at his own request on 31 December, 2010, to take on new challenges. 


You may also like

Personal Protection

Draeger introduces X-plore 8000 powered air purifying respirator

To help workers in the pharmaceutical sector breathe easy in harsh environments

DRAEGER OFFERS FREE COPIES OF NEW DRÄGERTUBE HANDBOOK

<p>Draeger is offering a free copy of the new DraegerTubes & CMS-Handbook to anyone with a need for short term gas detection. Available whilst stocks last, this 15th edition is packed with the latest information on more than 350 DraegerTubes and represents a definitive guide to the selection and use of short term tubes in line with current legislation.</p>

Easy infra-red upgrade and longer sensor life with explosion-proof Draeger Sensor IR

<p>Upgrading to infra-red technology has never been easier, or more cost effective, than with the longer-life, explosion-proof Draeger Sensor IR. </p>
Sustainability

Explosion-proof transmitter from Draeger

<p>Draeger Safety has launched the Draeger PIR 3000, a smart explosion proof infra-red gas transmitter that the company says ensures reliable detection of combustible gases and vapours.</p>
You need to be a subscriber to read this article.
Click here to find out more.
Drug Delivery

Autoinjector platforms: optimising device selection and unlocking manufacturing efficiency for injectable pipelines

Owing to ageing populations, the increased prevalence of chronic disease and additional pressure on global healthcare systems, among other factors, the market for drug delivery devices for self-administration (autoinjectors) is growing
Ingredients

Lubrizol to showcase game-changing excipients and nutraceutical ingredients at CPHI Frankfurt

Lubrizol partners with pharmaceutical and nutraceutical companies to develop innovative solutions that improve patient outcomes and offer consumer benefits
Research & Development

Quotient Sciences and CPI to accelerate RNA drug development with joint venture

The JV will address the growing industry demand for agile solutions that bring new RNA therapeutics to patients with greater speed and confidence
Subscribe now